Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2001-05-21
2003-08-26
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S463000, C424S489000, C424S490000, C424S499000, C424S477000, C424S485000
Reexamination Certificate
active
06610329
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to compositions useful for the delivery, and preferably the oral delivery, of antigens and adjuvants to animals. Methods for the preparation and for the administration of these compositions are also disclosed.
BACKGROUND OF THE INVENTION
Conventional means for delivering antigens to their intended targets are often severely limited by the presence of biological, chemical, and physical barriers. Typically, these barriers are imposed by the environment through which delivery must take place, the environment of the target for delivery, or the target itself.
Oral delivery of antigens would be the route of choice for administration to animals if not for physical barriers such as the mucous layer and the epithelial cells of the gastrointestinal (GI) tract. Oral delivery is also impeded by chemical barriers such as the pH in the GI tract and the presence in the oral cavity and the GI tract of powerful digestive enzymes. Furthermore, orally administered soluble and insoluble antigens can induce a non-responsive state or tolerance.
Methods for orally administering antigens have been developed which rely on the use of either attenuated microorganisms or polylactide/polyglycocide (PLA/PGA) microspheres to increase antigen presentation to and uptake by the appropriate antigen presenting cells. Attenuated organisms, unless properly delivered, can regain virulence, however. Additionally, broad spectrum use of PLA/PGA microspheres is not possible because these carriers require organic solvents that may alter or denature antigens. Furthermore, PLA/PGA systems are difficult to manufacture.
More recently, microspheres comprising artificial polymers of mixed amino acids (proteinoids) have been described for delivering biologically active agents including antigens. Santiago, et al.
Pharmaceutical Res
. Vol. 10, No. 8, (1993).
Adjuvants have been coadministered with antigens to increase the effectiveness of antigens, but adjuvants and antigen/adjuvant compositions are susceptible to the common problems of oral delivery described above.
Consequently, there is still a need in the art for simple, inexpensive, and easily prepared systems which can effectively deliver a broad range of antigens, particularly via the oral route.
SUMMARY OF THE INVENTION
The present invention provides compositions for delivering antigens. These compositions are suitable for delivery via the oral route and comprise:
(a) an antigen;
(b) an adjuvant; and
(c) at least one carrier comprising a member selected from the group consisting of;
(i) an acylated amino acid or a salt thereof;
(ii) a polyamino acid comprising at least one acylated amino acid or a salt thereof;
(iii) a sulfonated amino acid or a salt thereof;
(iv) a polyamino acid comprising at least one sulfonated amino acid or a salt thereof; or
(v) any combination thereof.
These compositions can be orally administered to animals to produce or prime and/or to boost an immunogenic response and to achieve immunization. When these compositions are used to boost immunogenic responses the prime can be delivered by the compositions of the present invention or other compositions.
Also contemplated are methods for preparing mixtures of microspheres of an antigen, an adjuvant, and a carrier as described above, and optionally, a dosing vehicle.
REFERENCES:
patent: 4183849 (1980-01-01), Hansen et al.
patent: 4238506 (1980-12-01), Stach et al.
patent: 4757066 (1988-07-01), Shiokari et al.
patent: 4835312 (1989-05-01), Itoh et al.
patent: 4878942 (1989-11-01), Motegi et al.
patent: 4900730 (1990-02-01), Miyauchi
patent: 4927928 (1990-05-01), Shroot et al.
patent: 5066487 (1991-11-01), Morelle et al.
patent: 5352461 (1994-10-01), Feldstein et al.
patent: 5447728 (1995-09-01), Milstein et al.
patent: 5451410 (1995-09-01), Milstein et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5629020 (1997-05-01), Leone-Bay et al.
patent: 5643957 (1997-07-01), Leone-Bay et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
patent: 5665700 (1997-09-01), Cho et al.
patent: 5693338 (1997-12-01), Milstein
patent: 5705529 (1998-01-01), Matyus et al.
patent: 5709861 (1998-01-01), Santiago et al.
patent: 5714167 (1998-02-01), Milstein et al.
patent: 5750147 (1998-05-01), Kantor
patent: 5766633 (1998-06-01), Milstein et al.
patent: 5773647 (1998-06-01), Leone-Bay et al.
patent: 5792451 (1998-08-01), Sarubbi et al.
patent: 5811127 (1998-09-01), Milstein et al.
patent: 5863944 (1999-01-01), Leone-Bay et al.
patent: 5866536 (1999-02-01), Leone-Bay et al.
patent: 5958457 (1999-09-01), Santiago et al.
patent: 5990166 (1999-11-01), Leone-Bay et al.
patent: 6001347 (1999-12-01), Leone-Bay et al.
patent: 6051258 (2000-04-01), Kantor
patent: 6051561 (2000-04-01), Leone-Bay et al.
patent: 6060513 (2000-05-01), Leone-Bay et al.
patent: 6071510 (2000-06-01), Leone-Bay et al.
patent: 6071538 (2000-06-01), Milstein et al.
patent: 6090958 (2000-07-01), Leone-Bay et al.
patent: 6099856 (2000-08-01), Milstein et al.
patent: 6100285 (2000-08-01), Kantor
patent: 6100298 (2000-08-01), Leone-Bay et al.
patent: 6180140 (2001-01-01), Leone-Bay et al.
patent: 6221367 (2001-04-01), Milstein et al.
patent: 6242495 (2001-06-01), Leone-Bay et al.
patent: 6245359 (2001-06-01), Milstein et al.
patent: 0036145 (1981-09-01), None
patent: 226223 (1987-06-01), None
patent: 0365183 (1989-10-01), None
patent: 0517211 (1992-09-01), None
patent: 0576941 (1993-06-01), None
patent: 369853 (1969-07-01), None
patent: 4446 (1966-11-01), None
patent: 2095994 (1982-10-01), None
patent: 48-37819 (1973-11-01), None
patent: 2239980 (1990-09-01), None
patent: 9219263 (1992-12-01), None
patent: 9747270 (1997-12-01), None
patent: 8807378 (1998-10-01), None
patent: WO 99/29705 (1999-06-01), None
patent: 0006184 (2000-02-01), None
patent: 0006534 (2000-02-01), None
patent: 0007979 (2000-05-01), None
patent: 0040203 (2000-07-01), None
patent: 0046182 (2000-08-01), None
patent: 0047188 (2000-08-01), None
patent: 0048589 (2000-08-01), None
patent: 0050386 (2000-08-01), None
patent: 0059480 (2000-10-01), None
patent: 0059863 (2000-10-01), None
patent: 0132130 (2001-05-01), None
patent: 0132596 (2001-05-01), None
patent: 0134114 (2001-05-01), None
patent: 0144199 (2001-06-01), None
patent: 0151454 (2001-07-01), None
Palagiano, F. et al.: “Synthesis, stability and anticonvulsant activity of two new GABA prodrugs,” Pharamazic, 52 (4): 272-276 (1997), XP-001084051.
Yalcin, I. et al.: “Synthesis and Microbiological Activity of Some Novel N-(2-Hydroxyl-5-Substitutedphenyl)Benzacetamides, Phenoxyacetamides and Thiophenoxycetamides as the Possible Metabolites of Antimicrobial Active Benzoxazoles,” Il farmaco, 52 (11), 685-689 (1997).
Gurrieri and Siracusa: “Thermal Condensation of Some alpha-aminoacids with Phatalic Acid” Thermochimica Acta, 7 (1973) 231-239.
Brown, G. and Foubister, A.J. “Receptor Binding Sites of Hypoglycemic Sulfonylureas and Related[(Acylamino)alkyl[]benzoic Acids J Med Chem 27, 79-81, 1984.
Amino Yusuke et al. Chem Pharm Bull 36 pp. 4426-4434 (1988).
Chem Abs 73548-12-6 (Apr. 1991).
Chem Abs 70204-54-5 (Apr. 1991).
Chem Abs 184360-83-342 (1975) Solubility and disassociation constants of some alicyclic acids.
Chemical Abstract, vol. 99(23) Abst. No. 191473h (1983).
Johansen, Marianne, et al. “The Kinetics of decompn. Of various N-Mannich bases of salicylamide” Int. J. Pharm. (1980), 7(2): 119-27 (1980).
Leone-Bay, Andrea; Santiago, Noemi; Achan, Douglas; Chaudhary, Kiran; DeMorin,Frenel; Falzarano, Lise; Haas, Susan; Kalbag, Suraj; Kaplan, David; Leipold, Harry; Lercara, Christine; O'Toole, Doris; Rivera, Theresa; Rosado, Connie; Sarubbi, Donald; Vuocolo, Edmund; Wang, NaiFang; Milstein, Sam and Baughman, Robert A; N-acylated alpha-amino acids as Novel Oral Delivery Agents for Proteins; Journal of Medicinal Chemistry (1995) 38: 4263-4269.
Leone-Bay, A. “N-Acylates alpah-amino acids as novel oral delivery agents for proteins” Journal of Medicinal Chemistry vol. 38, 4263-4269 (1995).
Santiago, N; Haas, S; Baughman, R.; “Vehicles for Oral Immunization” Vaccine De
Barantsevitch Evgueni
Haas Susan
Leone-Bay Andrea
Milstein Sam J.
Santiago Noemi B.
Channavajjala Lakshmi S.
Emisphere Technologies Inc.
LandOfFree
Compositions for the delivery of antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the delivery of antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the delivery of antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3076522